Long-term Follow-up of CAR T Cell Therapy

Recruiting in Palo Alto (17 mi)

+9 other locations

Age: Any Age

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 2

Waitlist Available

Sponsor: Autolus Limited

No Placebo Group

Prior Safety Data

Trial Summary

What is the purpose of this trial?Long-term follow-up of patients exposed to an AUTO CAR T cell therapy for up to 15 years following their first AUTO CAR T cell therapy infusion.

Eligibility Criteria

This trial is for patients who have previously received AUTO CAR T cell therapy as part of a clinical study. They must have agreed to long-term follow-up and be able to comply with the study's requirements.

Inclusion Criteria

Patients must have provided informed consent for long-term follow-up study prior to participation

Patients must be able to comply with the study requirements

I have received CAR T cell therapy as part of a clinical trial.

Exclusion Criteria

There are no specific exclusion criteria for this study.

Participant Groups

The trial involves long-term monitoring of patients treated with AUTO CAR T cell therapy, tracking their health for up to 15 years after their first infusion to assess lasting effects and outcomes.

1Treatment groups

Experimental Treatment

Group I: AUTO CAR T cell therapyExperimental Treatment1 Intervention

Patients who received previous treatment with AUTO CAR T Cell Therapy